Y-Intercept (HK)’s Guardian Pharmacy Services GRDN Stock Holding History

Y-Intercept (HK)’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Buy	+85,036	New	+$3.29M	0.07%	405

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Y-Intercept (HK)'s GRDN Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Guardian Pharmacy Services (GRDN) in Q2 2026: 85,036 shares worth $3.56M. The stake represents 0.07% of the portfolio and ranks #405 among its holdings.

189 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

Y-Intercept (HK) held 85,036 shares of Guardian Pharmacy Services worth $3.56M as of Q2 2026.
Guardian Pharmacy Services was a new Y-Intercept (HK) position in Q2 2026.
Guardian Pharmacy Services made up 0.07% of Y-Intercept (HK)'s portfolio in Q2 2026, its #405 holding.
189 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.